
News|Articles|August 17, 2026
Characterizing Conjugated Therapeutics: Advanced LC-MS Strategies for PQAs, Aggregates and Conjugation Sites
Author(s)SCIEX
Comprehensive characterization of biotherapeutics requires advanced analytical strategies capable of detecting and identifying low-abundant product quality attributes (PQAs), including post-translational modifications, aggregates, sequence variants, and conjugation sites. This eBook presents three technical articles demonstrating advanced LC-MS workflows that achieve up to 10X improvement in MS sensitivity for trace-level detection and confident identification of these challenging attributes.
Trending on LCGC International
1
HPLC-FLD Confirms Aflatoxins in Peanuts, Pistachios
2
Industry Roundup: Shimadzu Debuts GCMS-TQ RX Series, Tackling Helium Shortage and Laboratory Throughput Pressures
3
GC-MS Profiles Nano Garlic and Lemon Oils
4
GC×GC–TOF-MS Detects Persistent Organic Pollutants in Sediment
5
